No Patent for hESCs in Europe | GenomeWeb

The UK's Guardian reports that "the European Patent Office has refused a patent covering the use of human embryonic stem cells on the grounds that it would be contrary to 'public order or morality.'" Referring to it as a "landmark ruling," the article goes on to say that if the patent had been granted, observers feared it would thwart companies engaged in developing hESC-based technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.